Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.

Lopes, Alessandra; Vanvarenberg, Kevin; Préat, Véronique; Vandermeulen, Gaëlle

Lopes, Alessandra; Vanvarenberg, Kevin; Préat, Véronique; Vandermeulen, Gaëlle.

Afiliação

Lopes A; Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Avenue E. Mounier 73, B1.73.12, 1200 Brussels, Belgium.
Vanvarenberg K; Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Avenue E. Mounier 73, B1.73.12, 1200 Brussels, Belgium.
Préat V; Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Avenue E. Mounier 73, B1.73.12, 1200 Brussels, Belgium. Electronic address: veronique.preat@uclouvain.be.
Vandermeulen G; Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Avenue E. Mounier 73, B1.73.12, 1200 Brussels, Belgium.

Mol Ther Nucleic Acids ; 8: 404-415, 2017 Sep 15.

Article em En | MEDLINE | ID: mdl-28918040

Palavras-chave

CpG; DNA vaccine; P1A; P815; cancer vaccine; codon optimization; innate immunity; prophylactic; therapeutic vaccine; tumor vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google